Latest News

CIMT

Riikka CIMT

Head of R&D Riikka Havunen was awarded oral presentation “Oncolytic adenoviruses armed with tumor necrosis factor alpha and interleukin-2 enable treatment of solid tumors with T cell therapies” at the 16th Cancer Immunotherapy Annual Meeting in Mainz, Germany in May 2018.

Poster of the presentation was also presented in the meeting.

Latest News

Upcoming Events

Please contact our business development team to meet us at the following events:

1-2nd March 2023
Zurich, Switzerland
14-15th March 2023
Helsinki, Finland
20-22nd March 2023
Basel, Switzerland
15–16th May 2023
Dublin, Ireland
16-20th May 2023
Los Angeles (CA), USA
2-6th June 2023
Chicago (IL), USA
5-8th June 2023
Boston (MA), USA
13-14th September 2023
Boston (MA), USA
20-24th October 2023
Madrid, Spain
29-30th November
Copenhagen, Denmark